Interventions: VK2735 Primary Outcome Measure: Percentage change in body weight from baseline for participants receiving VK2735 after 78 weeks of treatment Time Frame: 78 weeks Study Details Source VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2) Sponsor: Viking Therapeutics Goal: This is a phase 3, multicenter, 78-week randomized, double-blind, placebo-controlled, parallel arm study that will evaluate the weight loss efficacy as well as safety, tolerability, pharmacodynamic effects, and pharmacokinetics of VK2735 in adults with Type 2 Diabetes who are obese or overweight
If you have any specific questions about the program, we are here to help If you are not getting the results you want, let us know and we will do everything we can to help you If you feel confused or frustrated, dont feel like a stranger
Testosterone influences factors such as skin thickness, oil production, and hair growth, making men's skin naturally thicker and more prone to oiliness
Keep Your Pets Active and Healthy We blend powerful peptides into easy-to-administer supplements, providing your pets with the optimal support for a happier and healthier life
Critical take-home points: Sometimes nodules require surgery
Psychiatry 67 RozenS.CudkowiczM